Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Funck, Jr. Robert E., holds the title of EXECUTIVE VICE PRESIDENT at ABBOTT LABORATORIES.
On 2023-03-01, the insider transacted 12,764 shares.The shares were transacted at a weighted average price of $99.86 per share, resulting in a total market-relevant value of $1.3M.
Funck, Jr. Robert E. (EXECUTIVE VICE PRESIDENT) sold $1.3M of $ABT
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.